Literature DB >> 23034523

Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals.

Charles DeCarli1.   

Abstract

Cerebrovascular risk factors and stroke are highly prevalent with advancing age, and stroke may be more common than Alzheimer's disease, particularly among older men. While stroke mortality continues to decline, the prevalence of individuals with various vascular risk factors continues to rise and many are undiagnosed or undertreated. Asymptomatic cerebrovascular brain injury that includes asymptomatic brain infarction and white matter hyperintensities as well as accelerated brain atrophy is even more frequent than clinical stroke. Moreover, the impact of cerebrovascular risk factors on brain injury appears to begin in middle life and additively increases the likelihood of later life dementia. This review focuses on the use of neuroimaging and genetics to understand the impact of asymptomatic vascular risk factors on the trajectories of cognitive aging as well as incident cognitive impairment, stroke, and mortality. Results of this review emphasize the need for early detection and treatment of vascular risk factors to improve the cognitive health of our rapidly aging population.

Entities:  

Mesh:

Year:  2013        PMID: 23034523      PMCID: PMC3786369          DOI: 10.3233/JAD-2012-129004

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  106 in total

1.  The lifetime risk of stroke: estimates from the Framingham Study.

Authors:  Sudha Seshadri; Alexa Beiser; Margaret Kelly-Hayes; Carlos S Kase; Rhoda Au; William B Kannel; Philip A Wolf
Journal:  Stroke       Date:  2006-01-05       Impact factor: 7.914

2.  Genome-wide scan for white matter hyperintensity: the Framingham Heart Study.

Authors:  Anita L DeStefano; Larry D Atwood; Joseph M Massaro; Nancy Heard-Costa; Alexa Beiser; Rhoda Au; Philip A Wolf; Charles DeCarli
Journal:  Stroke       Date:  2005-12-01       Impact factor: 7.914

3.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

4.  Different mechanisms of episodic memory failure in mild cognitive impairment.

Authors:  Christine Wu Nordahl; Charan Ranganath; Andrew P Yonelinas; Charles DeCarli; Bruce R Reed; William J Jagust
Journal:  Neuropsychologia       Date:  2005-02-05       Impact factor: 3.139

5.  Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.

Authors:  M Yoshita; E Fletcher; D Harvey; M Ortega; O Martinez; D M Mungas; B R Reed; C S DeCarli
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

6.  Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study.

Authors:  Rachel A Whitmer; Erica P Gunderson; Elizabeth Barrett-Connor; Charles P Quesenberry; Kristine Yaffe
Journal:  BMJ       Date:  2005-04-29

7.  Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study.

Authors:  Clinton B Wright; Myunghee C Paik; Truman R Brown; Sally P Stabler; Robert H Allen; Ralph L Sacco; Charles DeCarli
Journal:  Stroke       Date:  2005-05-05       Impact factor: 7.914

8.  White matter changes compromise prefrontal cortex function in healthy elderly individuals.

Authors:  Christine Wu Nordahl; Charan Ranganath; Andrew P Yonelinas; Charles Decarli; Evan Fletcher; William J Jagust
Journal:  J Cogn Neurosci       Date:  2006-03       Impact factor: 3.225

9.  Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study.

Authors:  Rhoda Au; Joseph M Massaro; Philip A Wolf; Megan E Young; Alexa Beiser; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli
Journal:  Arch Neurol       Date:  2006-02

10.  Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study.

Authors:  Sudha Seshadri; Anita L DeStefano; Rhoda Au; Joseph M Massaro; Alexa S Beiser; Margaret Kelly-Hayes; Carlos S Kase; Ralph B D'Agostino; Charles Decarli; Larry D Atwood; Philip A Wolf
Journal:  BMC Med Genet       Date:  2007-09-19       Impact factor: 2.103

View more
  24 in total

1.  Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury.

Authors:  Charles DeCarli; Sylvia Villeneuve; Pauline Maillard; Danielle Harvey; Baljeet Singh; Owen Carmichael; Evan Fletcher; John Olichney; Sarah Farias; William Jagust; Bruce Reed; Dan Mungas
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease.

Authors:  Katherine J Bangen; Daniel A Nation; Lisa Delano-Wood; Gali H Weissberger; Lawrence A Hansen; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2014-07-09       Impact factor: 21.566

3.  Vascular factors in neurodegenerative diseases: a path towards treatment and prevention.

Authors:  Gustavo C Román; François Boller
Journal:  Funct Neurol       Date:  2014 Apr-Jun

4.  Ratio of urine albumin to creatinine attenuates the association of dementia with hip fracture risk.

Authors:  Petra Bůžková; Joshua I Barzilay; Howard A Fink; John A Robbins; Jane A Cauley; Annette L Fitzpatrick
Journal:  J Clin Endocrinol Metab       Date:  2014-08-22       Impact factor: 5.958

Review 5.  Structural imaging measures of brain aging.

Authors:  Samuel N Lockhart; Charles DeCarli
Journal:  Neuropsychol Rev       Date:  2014-08-22       Impact factor: 7.444

6.  Neuroimaging of the aging brain: introduction to the special issue of neuropsychology review.

Authors:  Samuel Lockhart; Charles DeCarli; Rosemary Fama
Journal:  Neuropsychol Rev       Date:  2014-08-22       Impact factor: 7.444

Review 7.  Impact of multiple pathologies on the threshold for clinically overt dementia.

Authors:  Alifiya Kapasi; Charles DeCarli; Julie A Schneider
Journal:  Acta Neuropathol       Date:  2017-05-09       Impact factor: 17.088

8.  A link between type 2 diabetes and brain function.

Authors:  Christina E Hugenschmidt
Journal:  JAAPA       Date:  2013-12

9.  Contribution of cerebrovascular health to the diagnosis of Alzheimer disease.

Authors:  Karen M Rodrigue
Journal:  JAMA Neurol       Date:  2013-04       Impact factor: 18.302

Review 10.  Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2016-06-23       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.